New ProductsPursuant to Resolution No. 218/NQ-HĐQT dated March 10, 2022 of the Board of Directors of OPC Pharmaceutical Joint Stock Company on organizing the 2022 Annual General Meeting of Shareholders, announcement dated April 7, 2022 of the Board of Directors on the Invitation to the 2022 Annual General Meeting of Shareholders. Accordingly, OPC Pharmaceutical Joint Stock Company will hold the Annual General Meeting of Shareholders at 08:30 on April 29, 2022 at the Hall of OPC Pharmaceutical Joint Stock Company (1017 Hong Bang, Ward 12, District 6, Ho Chi Minh City).
The Congress program is expected to include the following main contents:
Report on the activities of the Board of Directors in 2021 and direction of activities in 2022
Report on the activities of the Executive Board in 2021 and direction of activities in 2022
Report on the activities of the Supervisory Board in 2021 and direction of activities in 2022
Proposal for approval of the audited 2021 Financial Statements
2021 profit distribution statement and 2022 profit distribution plan
Proposal to the General Meeting of Shareholders to authorize the Board of Directors to select an auditing company for the 2022 fiscal year
Proposal for issuing shares to increase share capital from owner’s equity
Some other contents fall under the authority of the General Meeting of Shareholders (if any).
All Congress documents have been disclosed according to regulations and posted on the Company’s website: https://opcpharma.com/quan-he-co-dong/
https://opcpharma.com/quan-he-co-dong/
